MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Cerus Corp

Fechado

SetorSaúde

1.48 1.37

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.46

Máximo

1.5

Indicadores-chave

By Trading Economics

Rendimento

-5.2M

-7.7M

Vendas

-7.6M

43M

EPS

-0.04

Margem de lucro

-17.85

Funcionários

614

EBITDA

-5.8M

-5.9M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+219.86% upside

Dividendos

By Dow Jones

Próximos Ganhos

31 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

34M

294M

Abertura anterior

0.11

Fecho anterior

1.48

Sentimento de Notícias

By Acuity

50%

50%

157 / 376 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Cerus Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de jul. de 2025, 15:46 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250 Million Private Placement

9 de jul. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 20:26 UTC

Ganhos

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 de jul. de 2025, 19:18 UTC

Conversa de Mercado

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 de jul. de 2025, 19:03 UTC

Conversa de Mercado

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 de jul. de 2025, 18:31 UTC

Conversa de Mercado

Some Fed Officials Supported Considering July Cut -- Market Talk

9 de jul. de 2025, 17:07 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk -2-

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 de jul. de 2025, 16:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 de jul. de 2025, 16:12 UTC

Conversa de Mercado

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 de jul. de 2025, 16:08 UTC

Conversa de Mercado

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 de jul. de 2025, 15:31 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250M Private Placement

9 de jul. de 2025, 15:31 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 de jul. de 2025, 15:27 UTC

Conversa de Mercado

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 de jul. de 2025, 14:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 de jul. de 2025, 14:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparação entre Pares

Variação de preço

Cerus Corp Previsão

Preço-alvo

By TipRanks

219.86% parte superior

Previsão para 12 meses

Média 4.67 USD  219.86%

Máximo 5 USD

Mínimo 4 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Cerus Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.3 / 1.36Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

157 / 376 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.